Shmuel Rubinstein


Shmuel has served as CEO of Taro Pharmaceuticals Ltd. (a public company traded on NASDAQ) for over 21 years and helped growing the company from about a 10Milion USD to over 400Milion USD . At the pick of his time as CEO, the company was valued at 2 billion USD. The company was located in Israel ,USA ,Canada and with several offices in Europe. Under his leadership the company got all GMP approvals and many approvals of products in the USA and Europe. After retiring from Taro , Shmuel is serving as a director and consultant in several Pharma companies in Israel and USA.